Bergholm U - Search Results

1

Prognostic value of bcl-2 immunoreactivity in medullary thyroid carcinoma.

Viale G, Roncalli M, Grimelius L, Graziani D, Wilander E, Johansson H, Bergholm U, Coggi G. Viale G, et al. Among authors: bergholm u. Hum Pathol. 1995 Sep;26(9):945-50. doi: 10.1016/0046-8177(95)90082-9. Hum Pathol. 1995. PMID: 7672794

2

Expression of c-Myc, TGF-alpha and EGF-receptor in sporadic medullary thyroid carcinoma.

Wang W, Johansson HE, Bergholm UI, Westermark KM, Grimelius LE. Wang W, et al. Among authors: bergholm ui. Acta Oncol. 1997;36(4):407-11. doi: 10.3109/02841869709001288. Acta Oncol. 1997. PMID: 9247102

3

Chromogranin A immunoreactivity compared with argyrophilia, calcitonin immunoreactivity, and amyloid as tumour markers in the histopathological diagnosis of medullary (C-cell) thyroid carcinoma.

Harach HR, Wilander E, Grimelius L, Bergholm U, Westermark P, Falkmer S. Harach HR, et al. Among authors: bergholm u. Pathol Res Pract. 1992 Feb;188(1-2):123-30. doi: 10.1016/s0344-0338(11)81167-2. Pathol Res Pract. 1992. PMID: 1594480

4

Apoptosis and Expression of the Proto-Oncogenes bcl-2 and p53 and the Proliferation Factor Ki-67 in Human Medullary Thyroid Carcinoma.

Wang W, Johansson H, Bergholm U, Wilander E, Grimelius L. Wang W, et al. Among authors: bergholm u. Endocr Pathol. 1996 Spring;7(1):37-45. doi: 10.1007/BF02739913. Endocr Pathol. 1996. PMID: 12114678

5

Incidence of sporadic and familial medullary thyroid carcinoma in Sweden 1959 through 1981. A nationwide study in 126 patients. Swedish MCT Study Group.

Bergholm U, Adami HO, Telenius-Berg M, Johansson H, Wilander E. Bergholm U, et al. Acta Oncol. 1990;29(1):9-15. doi: 10.3109/02841869009089985. Acta Oncol. 1990. PMID: 2310607

6

Histopathologic characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma. A nationwide study in Sweden. The Swedish MTC Study Group.

Bergholm U, Adami HO, Auer G, Bergström R, Bäckdahl M, Grimelius L, Hansson G, Ljungberg O, Wilander E. Bergholm U, et al. Cancer. 1989 Jul 1;64(1):135-42. doi: 10.1002/1097-0142(19890701)64:1<135::aid-cncr2820640123>3.0.co;2-g. Cancer. 1989. PMID: 2731109

7

A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma.

Alemi M, Lucas SD, Sällström JF, Bergholm U, Akerström G, Wilander E. Alemi M, et al. Among authors: bergholm u. Oncogene. 1997 May 1;14(17):2041-5. doi: 10.1038/sj.onc.1201042. Oncogene. 1997. PMID: 9160884

8

Nuclear DNA content and survival in medullary thyroid carcinoma. Swedish Medullary Thyroid Cancer Study Group.

Ekman ET, Bergholm U, Bäckdahl M, Adami HO, Bergström R, Grimelius L, Auer G. Ekman ET, et al. Among authors: bergholm u. Cancer. 1990 Feb 1;65(3):511-7. doi: 10.1002/1097-0142(19900201)65:3<511::aid-cncr2820650323>3.0.co;2-b. Cancer. 1990. PMID: 2297642

9

Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.

Zedenius J, Larsson C, Bergholm U, Bovée J, Svensson A, Hallengren B, Grimelius L, Bäckdahl M, Weber G, Wallin G. Zedenius J, et al. Among authors: bergholm u. J Clin Endocrinol Metab. 1995 Oct;80(10):3088-90. doi: 10.1210/jcem.80.10.7559902. J Clin Endocrinol Metab. 1995. PMID: 7559902

10

Medullary carcinoma of the thyroid with carcinoid-like features.

Harach HR, Bergholm U. Harach HR, et al. Among authors: bergholm u. J Clin Pathol. 1993 Feb;46(2):113-7. doi: 10.1136/jcp.46.2.113. J Clin Pathol. 1993. PMID: 8459030 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters